Hosoya KI - Search Results

1

Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs.

Ehrhardt C, Bäckman P, Couet W, Edwards C, Forbes B, Fridén M, Gumbleton M, Hosoya KI, Kato Y, Nakanishi T, Takano M, Terasaki T, Yumoto R. Ehrhardt C, et al. Among authors: hosoya ki. J Pharm Sci. 2017 Sep;106(9):2234-2244. doi: 10.1016/j.xphs.2017.04.011. Epub 2017 Apr 15. J Pharm Sci. 2017. PMID: 28416418 Review.

2

Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method.

Hosoya K, Sugawara M, Asaba H, Terasaki T. Hosoya K, et al. J Neurochem. 1999 Sep;73(3):1206-11. doi: 10.1046/j.1471-4159.1999.0731206.x. J Neurochem. 1999. PMID: 10461913 Free article.

3

In-vivo and in-vitro evidence of a carrier-mediated efflux transport system for oestrone-3-sulphate across the blood-cerebrospinal fluid barrier.

Kitazawa T, Hosoya K, Takahashi T, Sugiyama Y, Terasaki T. Kitazawa T, et al. J Pharm Pharmacol. 2000 Mar;52(3):281-8. doi: 10.1211/0022357001773968. J Pharm Pharmacol. 2000. PMID: 10757415

4

The blood-brain barrier efflux transporters as a detoxifying system for the brain.

Terasaki T, Hosoya K. Terasaki T, et al. Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):195-209. doi: 10.1016/s0169-409x(98)00088-x. Adv Drug Deliv Rev. 1999. PMID: 10837716

5

Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2.

Asaba H, Hosoya K, Takanaga H, Ohtsuki S, Tamura E, Takizawa T, Terasaki T. Asaba H, et al. J Neurochem. 2000 Nov;75(5):1907-16. doi: 10.1046/j.1471-4159.2000.0751907.x. J Neurochem. 2000. PMID: 11032880 Free article.

6

Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats.

Hosoya K, Asaba H, Terasaki T. Hosoya K, et al. Life Sci. 2000 Oct 20;67(22):2699-711. doi: 10.1016/s0024-3205(00)00861-4. Life Sci. 2000. PMID: 11105986

7

Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions.

Terasaki T, Hosoya K. Terasaki T, et al. Biol Pharm Bull. 2001 Feb;24(2):111-8. doi: 10.1248/bpb.24.111. Biol Pharm Bull. 2001. PMID: 11217075 Free article. Review.

8

mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.

Hosoya KI, Takashima T, Tetsuka K, Nagura T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T. Hosoya KI, et al. J Drug Target. 2000;8(6):357-70. doi: 10.3109/10611860008997912. J Drug Target. 2000. PMID: 11328662

9

Characterization of the amino acid transport of new immortalized choroid plexus epithelial cell lines: a novel in vitro system for investigating transport functions at the blood-cerebrospinal fluid barrier.

Kitazawa T, Hosoya K, Watanabe M, Takashima T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T. Kitazawa T, et al. Pharm Res. 2001 Jan;18(1):16-22. doi: 10.1023/a:1011014424212. Pharm Res. 2001. PMID: 11336348

10

Activation of carrier-mediated transport of L-cystine at the blood-brain and blood-retinal barriers in vivo.

Hosoya K, Saeki S, Terasaki T. Hosoya K, et al. Microvasc Res. 2001 Sep;62(2):136-42. doi: 10.1006/mvre.2001.2328. Microvasc Res. 2001. PMID: 11516242 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page